100 related articles for article (PubMed ID: 2129384)
1. Evaluation of polyvalent anti-Pseudomonas aeruginosa vaccine in phagocytic reaction.
Grzybek-Hryncewicz K; Gościniak G
Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):291-7. PubMed ID: 2129384
[TBL] [Abstract][Full Text] [Related]
2. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. III. Polyvalent serum against three mucoid immunotypes potentiates phagocytosis of all (7) mucoid immunotypes.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):195-203. PubMed ID: 3149178
[TBL] [Abstract][Full Text] [Related]
3. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. I. Induction of homologous immunity by nonmucoid strains of P. aeruginosa.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):177-84. PubMed ID: 2467637
[TBL] [Abstract][Full Text] [Related]
4. Phagocytosis and intracellular killing of mucoid and nonmucoid variants of Pseudomonas aeruginosa by polymorphonuclear leukocytes: effect of specific immune sera.
Gościniak G; Maresz-Babczyszyn J; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1984; 32(4):467-79. PubMed ID: 6442852
[TBL] [Abstract][Full Text] [Related]
5. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
Gościniak G; Grzybek-Hryncewicz K
Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
[TBL] [Abstract][Full Text] [Related]
6. Phagocytosis and intracellular killing of mucoid and nonmucoid Pseudomonas aeruginosa strains isolated from wounds of burned patients.
Gościniak G; Ladosz J; Maresz-Babczyszyn J; Sokalska M
Arch Immunol Ther Exp (Warsz); 1980; 28(4):619-23. PubMed ID: 6779776
[TBL] [Abstract][Full Text] [Related]
7. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.
Meshulam T; Obedeanu N; Merzbach D; Sobel JD
Clin Immunol Immunopathol; 1984 Aug; 32(2):151-65. PubMed ID: 6428788
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis and intracellular killing of Pseudomonas aeruginosa by peritoneal macrophages of mice.
Maresz-Babczyszyn J; Czarny A; Lagowska-Złotorzycka M
Arch Immunol Ther Exp (Warsz); 1984; 32(4):481-7. PubMed ID: 6442853
[TBL] [Abstract][Full Text] [Related]
9. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
10. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
Pier GB; Elcock ME
J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359
[TBL] [Abstract][Full Text] [Related]
11. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
12. A new polyvalent pseudomonas vaccine.
Merle P; Robbel L; Hungerer KD
Behring Inst Mitt; 1984 Nov; (76):113-20. PubMed ID: 6441560
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenic properties and specificity of pseudomonas aeruginosa polyvalent vaccine].
Schiller B; Lysakowska E; Owczarska K
Med Dosw Mikrobiol; 1981; 33(2):91-6. PubMed ID: 6170849
[No Abstract] [Full Text] [Related]
14. Anti-Pseudomonas immunoglobulin I. Immunization of sheep.
Schiller B; Buchowicz I; Korbecki M; Lysakowska E; Rudnicka W; Robaczewska E
Arch Immunol Ther Exp (Warsz); 1981; 29(5):627-33. PubMed ID: 6812540
[TBL] [Abstract][Full Text] [Related]
15. The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. I. Comparison of thirteen O groups of Ps. aeruginosa, with a polyvalent Ps. aeruginosa antigen-antibody reference system.
Hoiby N
Acta Pathol Microbiol Scand B; 1975 Aug; 83(4):321-7. PubMed ID: 808099
[TBL] [Abstract][Full Text] [Related]
16. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type.
Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F
J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704
[TBL] [Abstract][Full Text] [Related]
18. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
Baltimore RS; Mitchell M
J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976
[TBL] [Abstract][Full Text] [Related]
19. The enhancement of phagocytosis and intra-cellular killing of Pseudomonas aeruginosa and its common antigen (OEP) coated latex particles by mouse spleen macrophages to which anti-OEP-IgG and gentamicin have been added.
Haranaka K; Matsuo M; Mashimo K
Jpn J Exp Med; 1977 Feb; 47(1):35-40. PubMed ID: 404451
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental burn wound sepsis by postburn immunization with polyvalent Pseudomonas antigen.
Nance FC; Hines JL; Fulton RE; Bornside GH
Surgery; 1970 Jul; 68(1):248-53. PubMed ID: 10483476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
